These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2964551)

  • 1. Pharmacokinetics of buspirone as determined by ex vivo (3H)-DPAT binding.
    Sethy VH; Francis JW
    Life Sci; 1988; 42(10):1045-8. PubMed ID: 2964551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective increase in carbohydrate intake by rats treated with 8-hydroxy-2-(di-n-propylamino)-tetraline or buspirone.
    Luo SQ; Ransom T; Li ET
    Life Sci; 1990; 46(23):1643-8. PubMed ID: 2141379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR; Peroutka SJ
    Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
    Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism by 8-hydroxy-2(di-n-propylamino)tetraline and other serotonin agonists of muscarinic M1-type receptors coupled to inositol phospholipid breakdown in human IMR-32 and SK-N-MC neuroblastoma cells.
    Fowler CJ; Ahlgren PC; O'Neill C
    Life Sci; 1991; 48(10):959-67. PubMed ID: 1825686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB; Miquel MC; Gozlan H; Hamon M
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum.
    Schoemaker H; Langer SZ
    Eur J Pharmacol; 1986 May; 124(3):371-3. PubMed ID: 2942413
    [No Abstract]   [Full Text] [Related]  

  • 12. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
    J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of the hypothermic action of 8-hydroxy-2-(di-N-propylamino)tetralin, 1-(2-pyrimidinyl)piperazine and its derivatives].
    Komissarov IV; Dolzhenko AT; Obraztsova OG; Zin'kovskaia LIa
    Biull Eksp Biol Med; 1990 Mar; 109(3):275-7. PubMed ID: 2142007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina.
    Lima L; Schmeer C; Urbina M
    Neurochem Res; 1994 Mar; 19(3):249-55. PubMed ID: 8177365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
    Croci T; Landi M; Bianchetti A; Manara L
    Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection.
    Perry KW; Fuller RW
    Biochem Pharmacol; 1989 Oct; 38(19):3169-73. PubMed ID: 2530985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
    Beer M; Kennett GA; Curzon G
    Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
    Lecci A; Giuliani S; Santicioli P; Maggi CA
    J Pharmacol Exp Ther; 1992 Jul; 262(1):181-9. PubMed ID: 1352548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.